banner
VEGFR2-targeted peptide S1-modified nanoliposomes
Inquiry

Cat. No.: X26-05-ZQ2802

VEGFR2-targeted peptide S1-modified nanoliposomes

Synonym: VEGFR2-targeted peptide S1 modified NLs; VEGFR2-targeted S1 nanoliposomes; S1 peptide-functionalized VEGFR2-targeted nanoliposomes

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This advanced engineered sub-micron system features vascular endothelial growth factor receptor 2 targeted peptide functionalized nanoliposomes. The vesicle architecture utilizes a high-purity sub-micron phospholipid-cholesterol bilayer shell whose exterior boundary is surface-modified with specific vascular endothelial growth factor receptor 2 (VEGFR2) binding S1 targeting peptides linked via covalent polymer-lipid anchors. This precise surface modification alters the surface hydration parameters and sub-micron surface charge topography, establishing a dense target-mimetic ligand array that completely prevents physical vesicle aggregation across variable laboratory testing setups while leaving the internal aqueous core completely empty.
Source
Custom synthesis
Functional Group
VEGFR2-targeted S1 peptide
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.